# Charles S. Fuchs

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/charles-s-fuchs/

## Facts

| Field | Value |
| --- | --- |
| Citations | 114,924 |
| Field | Colorectal Cancer Treatments and Studies |
| h-index | 173 |
| i10-index | 768 |
| Last Known Institution | Yale Cancer Center |
| OpenAlex ID | https://openalex.org/A5049314303 |
| ORCID iD | https://orcid.org/0000-0003-1582-9842 |
| Works | 1,716 |

## Researcher papers

Showing 12 of 20.

- [Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial](https://scholariq.org/papers/ramucirumab-monotherapy-for-previously-treated-advanced-gastric-or-gastro/)
- [Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma](https://scholariq.org/papers/genomic-correlates-of-immune-cell-infiltrates-in-colorectal-carcinoma/)
- [Impact of Physical Activity on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803](https://scholariq.org/papers/impact-of-physical-activity-on-cancer-recurrence-and-survival-in-patients-with/)
- [Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer](https://scholariq.org/papers/genome-wide-association-study-identifies-variants-in-the-abo-locus-associated/)
- [<i>Fusobacterium nucleatum</i>and T Cells in Colorectal Carcinoma](https://scholariq.org/papers/i-fusobacterium-nucleatum-i-and-t-cells-in-colorectal-carcinoma/)
- [Genetic Mechanisms of Immune Evasion in Colorectal Cancer](https://scholariq.org/papers/genetic-mechanisms-of-immune-evasion-in-colorectal-cancer/)
- [Phase II Study of Temozolomide and Thalidomide in Patients With Metastatic Neuroendocrine Tumors](https://scholariq.org/papers/phase-ii-study-of-temozolomide-and-thalidomide-in-patients-with-metastatic/)
- [Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis](https://scholariq.org/papers/identification-of-genetic-susceptibility-loci-for-colorectal-tumors-in-a-genome/)
- [Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial](https://scholariq.org/papers/ramucirumab-with-cisplatin-and-fluoropyrimidine-as-first-line-therapy-in/)
- [Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer](https://scholariq.org/papers/genome-wide-meta-analysis-identifies-five-new-susceptibility-loci-for-pancreatic/)
- [Genome-wide association analysis identifies TXNRD2, ATXN2 and FOXC1 as susceptibility loci for primary open-angle glaucoma](https://scholariq.org/papers/genome-wide-association-analysis-identifies-txnrd2-atxn2-and-foxc1-as/)
- [Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial](https://scholariq.org/papers/ramucirumab-plus-pembrolizumab-in-patients-with-previously-treated-advanced-non/)

## Researcher topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Colorectal Cancer Screening and Detection](https://scholariq.org/topics/colorectal-cancer-screening-and-detection/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)

## Researcher university

- [Yale Cancer Center](https://scholariq.org/institutions/yale-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.